- Q1 2024 IMCD NV Earnings Call TranscriptApr 26, 2024€141.7 (-4.90%)Earnings
- Q3 2023 IMCD NV Earnings Call TranscriptNov 10, 2023€126.8 (-0.39%)Earnings
- Q2 2023 IMCD NV Earnings Call TranscriptAug 04, 2023€128.15 (-1.42%)Earnings
- Q1 2023 IMCD NV Earnings Call TranscriptApr 26, 2023€137.9 (-3.97%)Earnings
- Q4 2022 IMCD NV Earnings Call TranscriptFeb 24, 2023€143.4 (-2.45%)Earnings
- Q3 2022 IMCD NV Earnings Call TranscriptNov 10, 2022€141.5 (+6.31%)Earnings
- Q2 2022 IMCD NV Earnings Call TranscriptAug 04, 2022€152.8 (+0.20%)Earnings
- Q1 2022 IMCD NV Earnings Call TranscriptApr 29, 2022€152.7 (-1.13%)Earnings
- Q4 2021 IMCD NV Earnings Call TranscriptFeb 25, 2022€141.35 (+0.60%)Earnings
- Q3 2021 IMCD NV Earnings Call TranscriptNov 09, 2021€197.05 (+0.38%)Earnings
- Q2 2021 IMCD NV Earnings Call TranscriptAug 04, 2021€163.15 (+10.46%)Earnings
- Q1 2021 IMCD NV Earnings Call TranscriptApr 29, 2021€120.6 (-1.19%)Earnings
- Full Year 2020 IMCD NV Earnings Call TranscriptFeb 26, 2021€101.95 (-1.35%)Earnings
- Nine Months 2020 IMCD NV Earnings Call TranscriptNov 11, 2020€105.35 (+2.13%)Earnings
- IMCD N.V., Signet Excipients Private Limited - M&A Call TranscriptSep 15, 2020
- Half Year 2020 IMCD NV Earnings Call TranscriptAug 18, 2020€90.68 (-0.31%)Earnings
- Q1 2020 IMCD NV Trading Update Call TranscriptApr 20, 2020
- Full Year 2019 IMCD NV Earnings Call TranscriptFeb 27, 2020€76.6 (+1.26%)Earnings
- Nine Months 2019 IMCD NV Earnings Call TranscriptNov 12, 2019€72.9 (+1.32%)Earnings
- Half Year 2019 IMCD NV Earnings Call TranscriptAug 16, 2019€62 (-15.13%)Earnings
- Q1 2019 IMCD NV Earnings Call TranscriptMay 08, 2019€71.7 (+2.94%)Earnings
- Full Year 2018 IMCD NV Earnings Call TranscriptMar 01, 2019€69Earnings
Q2 2023 IMCD NV Earnings Call Transcript
Hello, and welcome to IMCD N.V. First Half Year 2023 Results. My name is Alicia, and I will be your coordinator for today's event. Please note this call is being recorded. (Operator Instructions)
I will now hand you over to Pieter van der Slikke, CEO, to begin today's conference. Thank you.
Yes. Thank you very much, Alicia. Good morning, everybody. I'm here with Hans Kooijmans as usual, and we will answer your questions in a moment. In 2022, we reported an unprecedented growth of 48% of our operating EBITA under exceptional circumstances. The exceptional circumstances were the result of strong price increases and high demand, partly caused by supply issues. This year, and the first 6 months, we see the reverse, soft demands and price pressure in certain segments. This resulted in the first 6 months of 2023 in a flat revenue and a decrease of our operating EBITA of 6%, and ForEx adjusted minus 3% to EUR 280 million.
Q2 was particularly weak, which was mainly driven
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)